Fever caused by hydroxyurea: a report of three cases and review of the literature.
Hydroxyurea (HU) is generally regarded as an effective and well-tolerated drug for the treatment of the chronic myeloproliferative syndromes. It has rarely been implicated as a cause of drug fever. We report two patients with primary thrombocythaemia and one patient with polycythaemia vera who developed fever and shaking chills during treatment with HU. Infection was highly suspected and all patients were examined extensively. The fever subsided after discontinuation of therapy with this drug. However, the fever recurred within 1 day after rechallenge. The mechanism of HU-induced fever remained unclear, but the experience in our patients and the reviewed cases in the literature are highly suggestive of a hypersensitivity reaction. Clinicians should be aware of this rare adverse effect.
van der Klooster
J M
JM
Department of Internal Medicine, St. Clara Ziekenhuis, Rotterdam, Netherlands.
Sucec
P M
PM
Stiegelis
W F
WF
Hagenbeek
A
A
D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D005334:Fever / Q000139:chemically induced*; D006801:Humans; D006918:Hydroxyurea / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D011086:Polycythemia / Q000188:drug therapy; D013922:Thrombocytosis / Q000188:drug therapy
D000970:Antineoplastic Agents; D006918:Hydroxyurea